Grant: Discovery Grants Program - Individual
Queen's University
$15,000.00
Statistical Methods in the Design and Analysis of Clinical Trials and Assessment of Prediction with Patient-Specific Information
FY 2017-18
Summary
In the next five years, I will develop new methods in estimation, testing and making statistical inference for the accuracy of prediction models built upon patient specific data. Prediction error will be studied for survival outcome data with various types of censoring, for cure-rate models which accommodate cured and uncured patient populations and for high dimensional data. The research is important for health and medical researchers who are making predictions for patients' prognostics, disease categories or responses to therapy. It is also an important area of methodological research in statistics in need of computational methods and theoretical development. I will train a Ph.D. student in dealing with these statistical challenges to build up the research in this area for both practical use and advancement of statistical science. I will also develop new methods for clinical trial design and analysis when the treatment effect varies with patients' biomarker measurements. One approach is to assume additional treatment effects on patient subsets defined on different biomarker thresholds. The other approach is nonparametric and allows the treatment effect to change with the biomarker without a pre-specified functional form. The threshold model approach is very useful for clinical researchers for its clear practical interpretation. I will supervise two M.Sc. students in building sample size designing guidelines for clinical researchers. I will train one Ph.D. student on theoretical and methodological study on various threshold models. The second approach is more general, and it provides a direct view of the treatment effect in a flexible form. I will train another Ph.D. student on developing the nonparametric models for various types of data. The planned work in this general direction aims to improve clinical trials through biomarker study, and adds a new frontier to the statistical research in Canada. It addresses the urgent statistical issues arising from clinical trial study on targeted treatments and personalized medicine.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
356016-2013
Name nom
Jiang, Wenyu
Department département
Mathematics and Statistics
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2013
Award amount
15000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
1205
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Mathematical sciences
Area of application fr
Sciences mathématiques
Research subject code
3005
Research subject group en
Statistics and probability
Research subject group fr
Statistique et probabilité
Research subject en
Biostatistics
Research subject fr
Biostatistiques
Partie
5
Nb partie
5
Application title
Statistical Methods in the Design and Analysis of Clinical Trials and Assessment of Prediction with Patient-Specific Information
Keyword
NSERC
Application summary
In the next five years, I will develop new methods in estimation, testing and making statistical inference for the accuracy of prediction models built upon patient specific data. Prediction error will be studied for survival outcome data with various types of censoring, for cure-rate models which accommodate cured and uncured patient populations and for high dimensional data. The research is important for health and medical researchers who are making predictions for patients' prognostics, disease categories or responses to therapy. It is also an important area of methodological research in statistics in need of computational methods and theoretical development. I will train a Ph.D. student in dealing with these statistical challenges to build up the research in this area for both practical use and advancement of statistical science. I will also develop new methods for clinical trial design and analysis when the treatment effect varies with patients' biomarker measurements. One approach is to assume additional treatment effects on patient subsets defined on different biomarker thresholds. The other approach is nonparametric and allows the treatment effect to change with the biomarker without a pre-specified functional form. The threshold model approach is very useful for clinical researchers for its clear practical interpretation. I will supervise two M.Sc. students in building sample size designing guidelines for clinical researchers. I will train one Ph.D. student on theoretical and methodological study on various threshold models. The second approach is more general, and it provides a direct view of the treatment effect in a flexible form. I will train another Ph.D. student on developing the nonparametric models for various types of data. The planned work in this general direction aims to improve clinical trials through biomarker study, and adds a new frontier to the statistical research in Canada. It addresses the urgent statistical issues arising from clinical trial study on targeted treatments and personalized medicine.